Exact Mass: 585.305

Exact Mass Matches: 585.305

Found 42 metabolites which its exact mass value is equals to given mass value 585.305, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

17-AAG

Tanespimycin

C31H43N3O8 (585.305)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic

   

17-AAG

({13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-[(prop-2-en-1-yl)amino]-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl}oxy)methanimidate

C31H43N3O8 (585.305)


   

5-(N-Hexadecanoyl)aminofluorescin

5-hexadecanamido-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid

C36H43NO6 (585.309)


   

5-Hexadecanoylaminofluorescein

N-{3,6-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9-xanthene]-5-yl}hexadecanamide

C36H43NO6 (585.309)


D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

   

Mobocertinib

propan-2-yl 2-[(4-{[2-(dimethylamino)ethyl](methyl)amino}-2-methoxy-5-(prop-2-enamido)phenyl)amino]-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate

C32H39N7O4 (585.3063)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

Val-Glu-Ile-Pro-Glu

Val-Glu-Ile-Pro-Glu

C26H43N5O10 (585.301)


   

Pro Gln Arg Trp

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]-3-(1H-indol-3-yl)propanoic acid

C27H39N9O6 (585.3023)


   

Pro Gln Trp Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-(1H-indol-3-yl)propanamido]pentanoic acid

C27H39N9O6 (585.3023)


   

Pro Arg Gln Trp

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C27H39N9O6 (585.3023)


   

Pro Arg Trp Gln

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C27H39N9O6 (585.3023)


   

Pro Trp Gln Arg

(2S)-5-carbamimidamido-2-[(2S)-4-carbamoyl-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]pentanoic acid

C27H39N9O6 (585.3023)


   

Pro Trp Arg Gln

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]-4-carbamoylbutanoic acid

C27H39N9O6 (585.3023)


   

Gln Pro Arg Trp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C27H39N9O6 (585.3023)


   

Gln Pro Trp Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C27H39N9O6 (585.3023)


   

Gln Arg Pro Trp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C27H39N9O6 (585.3023)


   

Gln Arg Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C27H39N9O6 (585.3023)


   

Gln Trp Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C27H39N9O6 (585.3023)


   

Gln Trp Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C27H39N9O6 (585.3023)


   

Arg Pro Gln Trp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C27H39N9O6 (585.3023)


   

Arg Pro Trp Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C27H39N9O6 (585.3023)


   

Arg Gln Pro Trp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C27H39N9O6 (585.3023)


   

Arg Gln Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C27H39N9O6 (585.3023)


   

Arg Trp Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C27H39N9O6 (585.3023)


   

Arg Trp Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C27H39N9O6 (585.3023)


   

8,10-Dihydroxydihydroergotamine

8,10-Dihydroxydihydroergotamine

C33H39N5O5 (585.2951)


   

Trp Pro Gln Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C27H39N9O6 (585.3023)


   

Trp Pro Arg Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C27H39N9O6 (585.3023)


   

Trp Gln Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C27H39N9O6 (585.3023)


   

Trp Gln Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C27H39N9O6 (585.3023)


   

Trp Arg Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C27H39N9O6 (585.3023)


   

Trp Arg Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C27H39N9O6 (585.3023)


   

Terdecamycin

Terdecamycin

C31H43N3O8 (585.305)


   

ebastine fumarate

ebastine fumarate

C36H43NO6 (585.309)


   

1,3,5-Tris(diphenylmethyl)-1,3,5-triazinane

1,3,5-Tris(diphenylmethyl)-1,3,5-triazinane

C42H39N3 (585.3144)


   

SalMeterol Xinafoate Adduct IMpurity

SalMeterol Xinafoate Adduct IMpurity

C36H43NO6 (585.309)


   

5-(N-Hexadecanoyl)aminofluorescin

5-(N-Hexadecanoyl)aminofluorescin

C36H43NO6 (585.309)


   

LNAPE 24:5;O

LNAPE 24:5;O

C29H48NO9P (585.3067)


   

PE 18:3/6:2;O

PE 18:3/6:2;O

C29H48NO9P (585.3067)


   

PE 20:4/4:1;O

PE 20:4/4:1;O

C29H48NO9P (585.3067)


   

PE 24:5;O

PE 24:5;O

C29H48NO9P (585.3067)


   

ST 21:1;O6;HexNAc

ST 21:1;O6;HexNAc

C29H47NO11 (585.3149)


   

ST 27:3;O6;Tau

ST 27:3;O6;Tau

C29H47NO9S (585.2971)